Explore
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Press release
Owkin and Proscia expand access to AI pre-screening for colorectal cancer patients
November 19, 2024
Owkin and Proscia expand access to AI pre-screening for colorectal cancer patients
November 19, 2024
Press release
Owkin announces MSIntuit® CRC v2, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer
October 29, 2024
Owkin announces MSIntuit® CRC v2, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer
October 29, 2024
Press release
Owkin announces partnership with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer
October 2, 2024
Owkin announces partnership with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer
October 2, 2024
Press release
IA et santé: l’AP-HP renouvelle son accord avec Owkin pour accélérer l'innovation IA au service des patients
September 26, 2024
IA et santé: l’AP-HP renouvelle son accord avec Owkin pour accélérer l'innovation IA au service des patients
September 26, 2024
Press release
Owkin collaborates with MSD to assess the impact of MSIntuit® CRC to accelerate patient identification for therapeutic decisions
August 19, 2024
Owkin collaborates with MSD to assess the impact of MSIntuit® CRC to accelerate patient identification for therapeutic decisions
August 19, 2024
Press release
Owkin and Finnish Biobanks collaborate to advance medical research
August 13, 2024
Owkin and Finnish Biobanks collaborate to advance medical research
August 13, 2024
Press release
Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395
May 23, 2024
Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395
May 23, 2024
Press release
Aster Insights and Owkin collaborate to accelerate research in breast cancer
April 12, 2024
Aster Insights and Owkin collaborate to accelerate research in breast cancer
April 12, 2024
In the media
Owkin has been named one of Forbes’ AI 50
April 11, 2024
Owkin has been named one of Forbes’ AI 50
April 11, 2024